
|Videos|February 25, 2016
Dr. Brian Nussenbaum on the Difficulties of Improving Survival in Larynx Cancer
Author(s)Brian Nussenbaum, MD, FACS
Nussenbaum says the current balance in the treatment paradigm of larynx cancer is between surreal and cure, all while maintaining a functional preservation for the patient.
Advertisement
Brian Nussenbaum, MD, FACS, Division Chief, Head and Neck Surgical Oncology, Department of Otolaryngology Head and Neck Surgery, Washington University, discusses trying to improve survival larynx cancer. Nussenbaum says the current balance in the treatment paradigm of larynx cancer is between surreal and cure, all while maintaining a functional preservation for the patient.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































